TRIMAS ANNOUNCES ACQUISITION OF INTERTECH
Our parent company, TriMas Corporation (NASDAQ: TRS), announced today that it has acquired Intertech Plastics (“Intertech”), a leading injection molding company specializing in manufacturing precision plastic parts for the medical, packaging, industrial and consumer goods industries.
“Intertech and TriMas Packaging’s family of businesses are a great strategic fit, and we are excited about the opportunities ahead,” said Fabio Salik, President of TriMas Packaging. “We have been expanding our dispenser and closure offerings in the pharmaceutical & nutraceutical market and the addition of Intertech will further strengthen our portfolio and know-how in the Life Sciences market to better serve our current customers and further expand our customer base.”
Intertech, founded by Noel Ginsburg in 1980, consists of two manufacturing facilities located in Denver, Colorado, which specialize in custom injection molding with advanced manufacturing capabilities for products used in medical applications, as well as products and assemblies for consumer and industrial applications. Intertech’s medical-related product offering, manufactured in a dedicated ISO 13485 certified facility with a Class 8 controlled environment and MedAccred® accreditations, includes highly-engineered and tight tolerance components used in vascular access and in vitro diagnostic applications. In a separate facility, Intertech manufactures injection-molded products for food, wellness, hospitality and e-commerce logistics applications. Intertech has invested in innovation efforts to commercialize sustainable resin technology, including the use of biopolymers and plant-based resins in specific packaging applications.
“We are excited to announce the addition of Intertech to the TriMas family of businesses,” said Thomas Amato, President and Chief Executive Officer of TriMas. “We look forward to supporting Intertech’s management team and leveraging the TriMas Business Model to accelerate the growth of products used in medical and health-related applications, end markets which we believe have attractive long-term growth characteristics.”
“We are pleased to work with TriMas, as we transition Intertech into its next phase of development,” said Noel Ginsburg, Intertech’s founder and majority shareholder. “We look forward to TriMas’ support and investments to enhance Intertech’s growth well into the future.” Jim Kepler, Intertech’s President, along with the Intertech leadership team, will stay on with the Company and will report to Fabio Salik, TriMas Packaging group’s President.
Salik continued, “We look forward to welcoming Intertech to our TriMas Packaging team and continuing to deliver on our strategic objectives to offer the best packaging and injection molding solutions for our customers.”
TriMas’ acquisition of Intertech represents TriMas’ sixth acquisition in the packaging market since early 2019, and its second with products, injection molding manufacturing capability and customer approvals in the medical technology end market.